Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST
Runben Biotechnology Market Cap
Runben Biotechnology has a market cap or net worth of 10.57 billion as of April 29, 2026. Its market cap has decreased by -23.53% in one year.
Market Cap
10.57B
Enterprise Value
9.43B
Revenue
1.57B
Ranking
n/a
PE Ratio
32.69
Stock Price
26.13
Market Cap Chart
Since October 17, 2023, Runben Biotechnology's market cap has increased from 8.93B to 10.57B, an increase of 18.34%. That is a compound annual growth rate of 6.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 10.58B | 7.97% |
| Dec 31, 2025 | 9.80B | 3.77% |
| Dec 31, 2024 | 9.45B | 28.44% |
| Dec 29, 2023 | 7.36B | -17.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C&S Paper Co.,Ltd | 11.14B |
| Guangdong Marubi Biotechnology | 9.88B |
| Shanghai Jahwa United | 13.85B |
| Chongqing Baiya Sanitary Products | 7.81B |
| Shanghai Flyco Electrical Appliance | 15.04B |
| Yunnan Botanee Bio-Technology Group Co.LTD | 17.47B |
| Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou | 6.18B |
| Mingchen Health | 6.09B |